---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-050435"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2025-05-19T23:59:59+00:00"
generated_at: "2026-05-21T01:17:03.076398+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve 2025 Equity Incentive Plan authorizing 3.47M new shares

## Summary
- Shareholders voted 20.3M for, 7.1M against to approve the 2025 Equity Incentive Plan.
- Plan authorizes 3,474,404 shares for issuance to employees, directors, and consultants.
- All eight director nominees elected; say-on-pay and auditor ratification also approved.
- Director compensation capped at $750k annually ($1M first year).
- Vesting minimum of one year for awards, except up to 5% of shares can have shorter vesting.

## SEC filing metadata
- accession: 0001104659-25-050435
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2025-05-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465925050435/0001104659-25-050435-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465925050435/tm2515549d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-050435
- JSON: https://secwatch.observer/filing/0001104659-25-050435.json
- Plain text: https://secwatch.observer/filing/0001104659-25-050435.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.